Elsevier

The Lancet

Volume 380, Issue 9850, 13–19 October 2012, Pages 1283-1285
The Lancet

Comment
Measuring progress on NCDs: one goal and five targets

https://doi.org/10.1016/S0140-6736(12)61692-4Get rights and content

First page preview

First page preview
Click to open first page preview

Cited by (73)

  • Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

    2021, The Lancet
    Citation Excerpt :

    The global importance of non-communicable diseases has led to their inclusion at the forefront of global progress targets, including a goal of 25% reduction in premature mortality from non-communicable diseases by 2025 outlined in the WHO global non-communicable disease monitoring framework and a third reduction by 2030 included in the UN Sustainable Development Goals (SDGs).11,12 Tobacco control has been identified as a crucial and necessary part of reaching these goals, with one in six non-communicable disease-related deaths being attributable to smoking tobacco use.13–17 As countries work towards meeting global progress targets for reducing the prevalence of smoking tobacco use and premature mortality from non-communicable diseases, timely data on the prevalence of smoking tobacco use and attributable disease are necessary to guide effective policy and planning.11,17

View all citing articles on Scopus
View full text